Veracyte reported $62.61M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 188.95M 15.88M
Agilent A:US USD 1.94B 75M
Anika Therapeutics ANIK:US USD 27.91M 1.56M
Arrowhead Research ARWR:US USD 122.01M 16.84M
Biocept BIOC:US USD 7.15M 2.46M
Bruker BRKR:US USD 913.8M 49.2M
Exact Sciences EXAS:US USD 412.75M 10.93M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Illumina ILMN:US USD 2.77B 104M
Immunogen IMGN:US USD 121.86M 18.22M
Intrexon XON:US USD 78.64M 26.22M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Laboratory Of America LH:US USD 3.08B 556.2M
Ligand Pharmaceuticals LGND:US USD 98.81M 36.43M
Myriad Genetics MYGN:US USD 137.2M 8.1M
Rigel Pharmaceuticals RIGL:US USD 65.21M 17.95M
Roche Holding ROG:VX 27.24B 170M
Sangamo Biosciences SGMO:US USD 111.71M 10.65M
Siemens SIE:GR EUR 41.28B 1.4B
Sonic Healthcare SHL:AU AUD 1.87B 217.77M
Thermo Fisher Scientific TMO:US USD 17.11B 6B
Veracyte VCYT:US USD 62.61M 4.26M